CD44 and lung carcinoma: We hypothesized that specific inhibition of ALDH by DEAB may sensitize the ALDH-sorted fractions of the three MPM cell lines as DEAB has been shown to inhibit ALDH in breast, leukemia and lung cancer cell lines, as well as the ALDHhigh/CD44+ cells in breast cancer [6,14].